CD44 and neoplasm: Then, Clarke’s group showed that EpCAMhigh/CD44+cells isolated from human CRC could establish a tumor in mice with morphological and phenotypic heterogeneity of the original tumor and concluded that CD44 and EPCAM markers could be considered robust CCSC markers [22].